These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3354699)

  • 1. Effect of experimental heart failure on peripheral sympathetic vasoconstriction.
    Wilson JR; Matthai W; Lanoce V; Frey M; Ferraro N
    Am J Physiol; 1988 Apr; 254(4 Pt 2):H727-33. PubMed ID: 3354699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nervous system control mechanisms in heart failure.
    Cohn JN
    Acta Med Scand Suppl; 1986; 707():15-20. PubMed ID: 2874690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
    DiBona GF; Sawin LL
    J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle metaboreflex-induced coronary vasoconstriction limits ventricular contractility during dynamic exercise in heart failure.
    Coutsos M; Sala-Mercado JA; Ichinose M; Li Z; Dawe EJ; O'Leary DS
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(7):H1029-37. PubMed ID: 23355344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced capacity of cardiac efferent sympathetic neurons to release noradrenaline and modify cardiac function in tachycardia-induced canine heart failure.
    Cardinal R; Nadeau R; Laurent C; Boudreau G; Armour JA
    Can J Physiol Pharmacol; 1996 Sep; 74(9):1070-8. PubMed ID: 8960400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac sympathetic afferent reflex in dogs with congestive heart failure.
    Wang W; Zucker IH
    Am J Physiol; 1996 Sep; 271(3 Pt 2):R751-6. PubMed ID: 8853400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.
    Arnolda L; McGrath BP; Cocks M; Johnston CI
    J Clin Invest; 1986 Sep; 78(3):674-9. PubMed ID: 3528220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion.
    Kramer RS; Mason DT; Braunwald E
    Circulation; 1968 Oct; 38(4):629-34. PubMed ID: 4300395
    [No Abstract]   [Full Text] [Related]  

  • 11. Sympathetic vasoconstriction during exercise in ambulatory patients with left ventricular failure.
    Wilson JR; Frey MJ; Mancini DM; Ferraro N; Jones R
    Circulation; 1989 May; 79(5):1021-7. PubMed ID: 2713971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postsynaptic adrenoceptor-mediated vasoconstriction in coronary and femoral vascular beds.
    Chen DG; Dai XZ; Bache RJ
    Am J Physiol; 1988 May; 254(5 Pt 2):H984-92. PubMed ID: 2896466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid chemoreceptor modulation of regional blood flow distribution during exercise in health and chronic heart failure.
    Stickland MK; Miller JD; Smith CA; Dempsey JA
    Circ Res; 2007 May; 100(9):1371-8. PubMed ID: 17431189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of captopril on sympathetic control of the heart and vasculature in dogs.
    Vollmer RR; Horovitz ZP; Harris DN; Murthy VS
    Clin Exp Hypertens A; 1987; 9(12):2095-111. PubMed ID: 3325200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
    Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
    Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methyldopa, reserpine and guanethidine on hindleg vascular resistance.
    Mohammed S; Gaffney TE; Yard AC; Gomez H
    J Pharmacol Exp Ther; 1968 Apr; 160(2):300-7. PubMed ID: 5651373
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of adenosine to the depression of sympathetically evoked vasoconstriction induced by systemic hypoxia in the rat.
    Coney AM; Marshall JM
    J Physiol; 2003 Jun; 549(Pt 2):613-23. PubMed ID: 12702736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure.
    Al-Hesayen A; Parker JD
    Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic factor attenuates sympathetic neuroeffector responses in hindlimb vasculature of rabbits.
    Patel KP
    Can J Physiol Pharmacol; 1989 Sep; 67(9):1101-5. PubMed ID: 2532057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of morphine on the peripheral vascular response to sympathetic stimulation.
    Ward JM; McGrath RL; Weil JV
    Am J Cardiol; 1972 May; 29(5):659-66. PubMed ID: 5021495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.